Mass spectrometric data from 125 breast tumour samples showed CTHRC1, POSTN and MMP13 to all be significantly higher in breast tumour tissue relative to normal while SFRP4 and FNDC1 levels were unaffected (Fig 6A). This evidence concerns the gene POSTN and breast neoplasm.